Treatment of supraventricular tachycardias in the new millennium - Drugs or radiofrequency catheter ablation?

European Journal of Pediatrics

Volumn 160, Issue 1, 2001, Pages 1-9

  Bauersfeld, Urs ^a   Pfammatter, Jean Pierre ^b   Jaeggi, Edgar ^c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Anti arrhythmia agents; Catheter ablation; Supraventricular tachycardia

Indexed keywords

ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; PROCAINAMIDE; PROPAFENONE; SOTALOL; VERAPAMIL;

AGE DISTRIBUTION; ALGORITHM; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; CATHETER ABLATION; CHILD; CLINICAL FEATURE; DRUG INDICATION; ELECTROCARDIOGRAPHY; HUMAN; INFANT; MORBIDITY; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; WOLFF PARKINSON WHITE SYNDROME;

EID: 0035165688     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00008409     Document Type: Review

References (52)

1. Pediatric therapeutic catheterization
2. Treatment of atrial ectopic tachycardia in infants < 6 months old
3. Pathological observations of radiofrequency catheter ablation of cardiac tissue
4. Impact of clinical history and electrophysiologic characterization of accessory pathways on managment strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome
5. Radiation exposure during radiofrequency ablation of accessory atrioventricular connections
6. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction
7. Radiofrequency ablation of incessant, medically resistant supraventricular tachycardia in infants and small children
8. Physical aspects of radiofrequency energy applications
9. Amiodarone in the treatment of cardiac arrhythmias in children: 135 cases
10. Acute termination of supraventricular tachyarrhythmias in children by transesophageal atrial pacing
11. Clinical efficacy and safety of intravenous amiodarone in infants and children
12. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide
13. Catheter ablation of permanent junctional reciprocating tachycardia with radiofrequency current
14. Electrophysiologic studies of supraventricular tachycardia in children. II. Prediction of specific mechanism by noninvasive features
15. Management of the child with Wolff-Parkinson-White syndrome and supraventricular tachycardia: Model for cost effectiveness
16. Long-term follow-up of amiodarone therapy in the young: Continued efficacy, unimpaired growth, moderate side effects
17. Oral propafenone therapy for children with arrhythmias: Efficacy and adverse effects in mid-term follow-up
18. Fetal atrial flutter: Diagnosis, clinical features, treatment, and outcome
19. Adenosine-induced atrial proarrhythmia in children
20. Successful radiofrequency ablation in an infant with drug-resistant permanent junctional reciprocating tachycardia
21. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study)
22. Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease
23. Permanent junctional reciprocating tachycardia: A multicenter long-term follow-up study in infants, children and young adults
24. Radiation exposure to patients and medical personnel during radiofrequency catheter ablation for supraventricular tachycardia
25. Effectiveness of oral sotalol for treatment of pediatric arrhythmias
26. Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children
27. Incidence of femoral vein occlusion after catheter ablation in children: Evaluation with magnetic resonance
28. Pharmacology and electrophysiology of antiarrhythmic drugs
29. Radio-frequency ablation as treatment for cardiac arrhythmias
30. Ventricular fibrillation following adenosine therapy for supraventricular tachycardia in a neonate with concealed Wolff-Parkinson-White syndrome treated with digoxin
31. Natural history and management strategies of automatic atrial tachycardia in children
32. Fetal tachycardia: Mechanisms and predictors of hydrops fetalis
33. Adenosine: An effective and safe antiarrhythmic drug in pediatrics
34. Relation of syncope in young patients with Wolff-Parkinson-White syndrome to rapid ventricular response during atrial fibrillation
35. Pediatric use of intravenous amiodarone: Efficacy and safety in critically ill patients from a multicenter protocol
36. Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood
37. Efficacy and proarrhythmia of oral sotalol in pediatric patients
38. Effects of verapamil on supraventricular tachycardia in children
39. Untoward reaction to adenosine therapy for supraventricular tachycardia
40. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac arrhythmias
41. Late enlargement of radiofrequency lesions in infant lambs. Implications for ablation procedures in small children
42. Mechanism and therapy of complex arrhythmias in pediatric patients
43. Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children
44. Sotalol for refractory arrhythmias in pediatric and young adult patients: Initial efficacy and long-term Outcome
45. Five-year experience with radiofrequency catheter ablation: Implications for manangement of arrhythmias in pediatric and young adult patients
46. Aborted sudden death in the Wolff-Parkinson-White syndrome
47. Indications for radiofrequency ablation in the pediatric population
48. Percutaneous radiofrequency catheter ablation for supraventricular arrhythmias in children
49. A classification of antiarrhythmic actions reassessed after a decade of new drugs
50. Evolving concepts in the management of congenital junctional ectopic tachycardia. A multicenter study
51. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants
52. The response of pediatric arrhythmias to inravenous and oral flecainide